Roche Highlights Gazyva Progress, Reports Data on Enspryng, MS Drug
Roche RHHBY announced that the FDA has accepted its supplemental application for Gazyva/Gazyvaro (obinutuzumab) to treat systemic lupus…
Roche Highlights Gazyva Progress, Reports Data on Enspryng, MS Drug
Roche RHHBY announced that the FDA has accepted its supplemental application for Gazyva/Gazyvaro (obinutuzumab) to treat systemic lupus…